Inverse association between serum resistin and insulin resistance in humans

Diabetes Research and Clinical Practice

Volumn 82, Issue 2, 2008, Pages 256-261

  Dominguez Coello S ^a   Cabrera de Leon A ^a,b,c   Almeida Gonzalez D ^a   Gonzalez Hernandez A ^a   Rodriguez Perez M C ^a   Fernandez Ramos N ^a   Brito Diaz B ^a   Castro Fuentes, R ^a,c   Aguirre Jaime, A ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b San Juan de Dios Hospital   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Antihypertensive agents; Insulin resistance; Physical activity; Resistin; Waist to hip ratio

Indexed keywords

CYTOKINE; RESISTIN;

ABDOMINAL OBESITY; ADULT; AGED; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; SPAIN; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RESISTIN; SPAIN; WAIST-HIP RATIO;

EID: 54549090874     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.08.001     Document Type: Article

References (33)

1. Fain J.N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 74 (2006) 443-477
2. Banerjee R.R., Rangwala S.M., Shapiro J.S., et al. Regulation of fasted blood glucose by resistin. Science 303 (2004) 1195-1198
3. Perseghin G., Burska A., Lattuada G., et al. Increased serum resistin in elite endurance athlete with high insulin sensitivity. Diabetología 49 (2006) 1893-1900
4. Reilly M.P., Lehrke M., Wolfe M.L., et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 (2005) 932-939
5. Yagmur E., Trautwein C., Gressner A.M., and Tacke F. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am. J. Gastroenterol. 101 (2006) 1244-1252
6. Lu H.L., Wang H.W., Wen Y., et al. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. World J. Gastroenterol. 12 (2006) 1747-1751
7. Iqbal N., Seshadri P., Stern L., et al. Serum resistin is not associated with obesity or insulin resistance in humans. Eur. Rev. Med. Pharmacol. Sci. 9 (2005) 161-165
8. Vilarrasa N., Vendrell J., Maravall J., et al. Distribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy population. Clin. Endocrinol. (Oxford) 63 (2005) 329-335
9. Heilbronn L.K., Rood J., Janderova L., et al. Relationship between serum resistin concentrations and insulin resistence in nonobese, obese and obese diabetic subjects. J. Clin. Endocrinol. Metabolism. 89 (2004) 1844-1848
10. Utzschneider K.M., Carr D.B., Tong J., et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 48 (2005) 2330-2333
11. Cabrera de León A., González D.A., Méndez L.I., et al. Leptin and altitude in the cardiovascular diseases. Obes. Res. 12 (2004) 1492-1498
12. Cabrera de León A., Coello S.D., Rodríguez Pérez M.C., et al. A simple clinical score for type 2 diabetes mellitus screening. Diab. Res. Clin. Pract. 80 (2008) 128-133
13. Ainsworth B.E., Haskell W.L., Leon A.S., et al. Compendium of physical activities: energy costs of human movement. Med. Sci. Sports Exerc. 25 (1993) 71-80
14. Bernstein S.M., Morabia A., and Sloutskis D. Definition and prevalence of sedentarism on an urban population. Am. J. Public Health 89 (1999) 862-867
15. Norata G.D., Ongari M., Garlaschelli K., et al. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur. J. Endocrinol. 156 (2007) 279-284
16. Osawa H., Tabara Y., Kawamoto R., et al. Plasma resistin, associated with single nucleotide polymorphism-420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care 30 (2007) 1501-1506
17. Hivert M.F., Sullivan L.M., Fox C.S., et al. Associations of adiponectin, resistin, and TNFα with insulin resistance. J. Clin. Endocrin. Metab. (20 May 2008) (Epub ahead of print)
18. Silha J.V., Krsek M., Skrha J.V., et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur. J. Endocrinol. 149 (2003) 331-335
19. Lee J.H., Chan J.L., Yiannakouris N., et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant and diabetic subjects. J. Clin. Endocrinol. Metab. 88 (2003) 4848-4856
20. Yannakoulia M., Yiannakouris N., Blüher S., et al. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin and resistin concentrations in healthy humans. J. Clin. Endocrinol. Metab. 88 (2003) 1730-1736
21. Monzillo L.U., Hamdy O., Horton E.S., et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes. Res. 11 (2003) 1048-1054
22. Chen C.C., Li T.C., Li C.I., et al. Serum resistin level among healthy subjects: relationship to anthropometric an metabolic parameters. Metabolism 54 (2005) 471-475
23. Bo S., Gambino R., and Pagani A. Relationships between human serum resistin, inflammatory markers and insulin resistence. Int. J. Obes. (Lond.) 29 (2005) 1315-1320
24. Vozarova de Courten B., Degawa-Yamauchi M., Considine R.V., and Tataranni P.A. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 53 (2004) 1279-1284
25. Farvid M.S., Ng T.W.K., Chan D.C., et al. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia. Diab. Obes. Metab. 7 (2005) 406-413
26. Araki K., Masaki T., Katsuragi I., et al. Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension 48 (2006) 51-57
27. Maca-Meyer N., Villar J., Perez-Mendez L., et al. A tale of aborigins, conqueors and slaves: Alu insertion polymorphisms and the peopling of Canary Islands. Ann. Hum. Genet. 68 (2004) 600-605
28. Menzaghi C., Coco A., Salvemini L., et al. Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J. Clin. Endocrinol. Metab. 91 (2006) 2792-2795
29. Lehrke M., Reilly M.P., Millington S.C., et al. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 1 (2004) e45
30. Carey A.L., Petersen E.W., Bruce C.R., et al. Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion. Diabetologia 49 (2006) 1000-1007
31. Wake D.J., Strand M., Rask E., et al. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin. Endocrinol. 66 (2007) 440-446
32. González Hernández A., Cabrera de León A., Domínguez Coello S., et al. Serum resistin and polymorphisms of androgen receptor CAG(n) and GGN(n) and Aromatase TTTA(n). Obesity 5 Jun (2008) (Epub ahead of print)
33. Gerber M., Boettner A., Seidel B., et al. Serum resistin levels of obese an lean children and adolescents: biochemical analysis and clinical relevance. J. Clin. Endocrinol. Metab. 90 (2005) 4503-4509